Nimotuzumab and Radiotherapy in Pediatric Patients With Glioma (POLARIS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01145170
Recruitment Status : Completed
First Posted : June 16, 2010
Last Update Posted : July 27, 2015
Centro de Immunologia Molecular, Cuba
Information provided by (Responsible Party):
Eurofarma Laboratorios S.A.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : June 2014
  Study Completion Date : July 2014